您的位置: 首页 > 农业专利 > 详情页

COMBINAISON D'OXYMÉTAZOLINE ET D'IPRATROPIUM EN APPLICATION TOPIQUE NASALE POUR LE TRAITEMENT DE LA TOUX
专利权人:
Pablo;Cortés Borrego
发明人:
申请号:
EP16871105.9
公开号:
EP3384909A4
申请日:
2016.03.17
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention is effective for the treatment and relief of cough produced by posterior nasal secretion, through the use of the combination of Oximetazoline and Ipratropium. The active agents enunciated in the combination of the present invention have been used and marketed separately with different uses to those of the present invention. The oxymetazoline to eliminate nasal secretion and congestion (obstruction), and ipratropium bromide is marketed for the purpose of dilating the bronchial tubes in asthmatic patients with chronic obstructive pulmonary disease, although experimentally it has also been used to decrease nasal secretion. Both active agents, together or separately have not been used so far as antitussives intranasally. The cough produced by the posterior nasal secretion, is the most frequent cause of cough in the human being of any age, the present invention is effective for the treatment and relief of said symptom.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充